Document is current
Any future updates will be listed below
-
Authors
Merz, Alexandra
Mohamed, Amro
Corbett, Cheyenne
Herring, Kris
Hildenbrand, Jordan
Locke, Susan C.
Patierno, Steven
Troy, Jesse
Wolf, Steven
Zafar, S. Yousuf
Chilcott, Jack
Higgins, Adam
Manassei, Hugo
McCoy, Colette
Buckingham, Trudy L.
LeBlanc, Thomas W. https://orcid.org/0000-0002-0546-7895
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 7 March 2022
Accepted: 11 June 2022
First Online: 20 June 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of the Duke University School of Medicine (PRO00092123).
: Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent to participate in the study, which includes publishing deidentified data.
: Researchers declare the following conflicts of interest: TWL reports personal fees for consulting or advisory boards from AbbVie, Agios/Servier, AstraZeneca, Astellas, CareVive, BMS/Celgene, Genentech, GSK, Pfizer, and Seattle Genetics; royalties from UpToDate; speakers bureau fees from Agios, AbbVie, and BMS/Celgene; grants and/or research contracts from the American Cancer Society, AstraZeneca, BMS, Jazz Pharmaceuticals, the NINR/NIH, and Seattle Genetics.
